Literature DB >> 17883594

Tissue factor-dependent blood coagulation is enhanced following delivery irrespective of the mode of delivery.

K Boer1, I A den Hollander, J C M Meijers, M Levi.   

Abstract

BACKGROUND: The risk of thrombosis is clearly increased in the postpartum period. Mice with a targeted deletion of the transmembrane domain of tissue factor (TF) develop serious activation of blood coagulation and widespread thrombosis after delivery. OBJECTIVE AND METHODS: We hypothesized that TF, abundantly present in placental tissue, is released during delivery, resulting in the activation of blood coagulation. We measured sensitive markers for TF-dependent activation of coagulation before and after induction of labor in two groups: a vaginal delivery (VAG) group and a cesarean section (CS) group.
RESULTS: One hour after delivery, soluble TF (sTF) significantly increased in both groups [VAG group (mean +/- SD) 226 +/- 42 to 380 +/- 42 pg mL(-1) and CS group 193 +/- 17 to 355 +/- 44 pg mL(-1)]. The day after delivery, sTF was somewhat less increased. Both groups also showed an increase in factor VIIa, indicating activation of the TF pathway of coagulation. Indeed, after delivery, TF-dependent coagulation, as measured by the TF clotting time assay, was significantly enhanced. Increased plasma levels of prothrombin fragment 1 + 2 and thrombin-antithrombin complexes demonstrated thrombin generation following delivery. TF pathway-dependent activation of coagulation upon delivery was not blocked by TF pathway inhibitor and was not dependent on the mode of delivery.
CONCLUSION: The postdelivery increase in TF-dependent activation of coagulation is likely to be a natural mechanism to prevent excessive blood loss during and after delivery, and may also indicate a novel mechanism by which puerperal women have an increased risk of venous thromboembolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17883594     DOI: 10.1111/j.1538-7836.2007.02767.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  5 in total

Review 1.  Risk stratification for pregnancy-associated venous thromboembolism: Potential role for global coagulation assays.

Authors:  David O'Keefe; Hui Yin Lim; Lisa Hui; Prahlad Ho
Journal:  Obstet Med       Date:  2021-08-05

2.  Intrapartum anti-disseminated intravascular coagulation therapy leading to successful vaginal delivery following intrauterine fetal death caused by placental abruption: a case report.

Authors:  Michiko Honda; Shigetaka Matsunaga; Sumiko Era; Yasushi Takai; Kazunori Baba; Hiroyuki Seki
Journal:  J Med Case Rep       Date:  2014-12-23

3.  To Clot or Not: HELLP Syndrome and Disseminated Intravascular Coagulation in an Eclamptic Patient with Intrauterine Fetal Demise.

Authors:  Justin Walker; Anthony Bonavia
Journal:  Case Rep Anesthesiol       Date:  2020-07-07

4.  Inhibitory effects of amniotic fluid on the activated protein C anticoagulation system in maternal plasma.

Authors:  Divyanu Jain; Tomoaki Oda; Kenta Kawai; Yoshimasa Horikoshi; Masako Matsumoto; Megumi Narumi; Yukiko Kohmura-Kobayashi; Naomi Furuta-Isomura; Chizuko Yaguchi; Toshiyuki Uchida; Kazunao Suzuki; Naohiro Kanayama; Hiroaki Itoh; Naoaki Tamura
Journal:  J Thromb Thrombolysis       Date:  2021-07-06       Impact factor: 2.300

5.  Circulatory Neutrophils Exhibit Enhanced Neutrophil Extracellular Trap Formation in Early Puerperium: NETs at the Nexus of Thrombosis and Immunity.

Authors:  Stavros Giaglis; Chanchal Sur Chowdhury; Shane Vontelin van Breda; Maria Stoikou; André N Tiaden; Douglas Daoudlarian; Guenther Schaefer; Andreas Buser; Ulrich A Walker; Olav Lapaire; Irene Hoesli; Paul Hasler; Sinuhe Hahn
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.